Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Abrocitinib Treatment Adjusted for Atopic Dermatitis
December 2025
Abrocitinib treatment can be personalized in moderate-to-severe atopic dermatitis using flexible dosing to meet disease trajectory.
Read more
17 Oct 2025
Melanoma Quality of Life During and After Immunotherapy
Melanoma quality of life differs during and after immunotherapy, with fatigue, skin issues, and sexual dysfunction.
15 Oct 2025
Animal Exposure to Treatment Failure: Optimized Regimens in Brucellosis
Network meta-analysis ranks brucellosis treatment regimens, finding triple-drug combinations outperform widely used dual therapies.
10 Oct 2025
Biologic Therapy Shortens Hospital Stay in Pediatric GPP
Children with moderate-to-severe generalized pustular psoriasis (GPP) benefit significantly from biologic therapy.
8 Oct 2025
US Prevalence of Cutaneous Venous Malformations Higher Than Expected
Cutaneous venous malformations (cVMs), rare vascular anomalies marked by progressive vessel dilation, pain, ulceration, and bleeding, may be more prevalent in the US than previously recognized.
3 Oct 2025
Combined Radiation and Chemotherapy Offer Safer Path in Angiosarcoma
Helical tomotherapy combined with paclitaxel demonstrated encouraging survival outcomes with manageable toxicity in patients with cutaneous angiosarcoma.
1 Oct 2025
Can Biologic Therapy Be Safely Used in HS?
Adalimumab use in patients with hidradenitis suppurativa (HS) appears safe with appropriate prophylaxis, as no cases of hepatitis B virus (HBV) or tuberculosis (TB) reactivation were observed in a large retrospective analysis.
26 Sep 2025
A Step Forward Against Chronic Kidney Disease Itch
Dupilumab may provide meaningful relief for patients with chronic kidney disease who experience uremic pruritus and for those with atopic dermatitis complicated by renal impairment, according to a retrospective real-world study.
24 Sep 2025
Six Months to Better Outcomes in Vitiligo?
Oral JAK inhibitors appear effective and safe in the treatment of vitiligo, according to a retrospective study evaluating real-world outcomes in nearly 100 patients.
Loading posts...
« Previous
1
2
3
4
5
6
…
20
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View